Sage Therapeutics (NASDAQ:SAGE – Free Report) had its price objective reduced by Scotiabank from $34.00 to $19.00 in a research note published on Thursday morning, Benzinga reports. They currently have a sector outperform rating on the biopharmaceutical company’s stock. Several other research firms also recently weighed in on SAGE. Bank of America downgraded Sage Therapeutics […]
Archer-Daniels-Midland (NYSE:ADM – Get Free Report) will announce its earnings results before the market opens on Tuesday, April 23rd. Analysts expect the company to announce earnings of $1.35 per share for the quarter. Archer-Daniels-Midland has set its FY 2024 guidance at 5.250-6.250 EPS and its FY24 guidance at $5.25-6.25 EPS.Parties interested in registering for the […]
Equities research analysts at StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a report released on Sunday. The firm set a “hold” rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance Shares of PIRS stock opened at $0.15 on Friday. The business’s fifty day moving average price is […]
Calamos Wealth Management LLC acquired a new stake in shares of NetEase, Inc. (NASDAQ:NTES – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 16,125 shares of the technology company’s stock, valued at approximately $1,502,000. Several other institutional […]
Handelsbanken Fonder AB lessened its holdings in NetEase, Inc. (NASDAQ:NTES – Free Report) by 20.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 686,618 shares of the technology company’s stock after selling 181,360 shares during the quarter. Handelsbanken Fonder AB owned approximately 0.11% of […]